Chris Foley, Chief Scientist & Managing Director, and Zhana Kuncheva, Director of Health Data Science at bioXcelerate AI, were co-editors for a special issue in Frontiers “Methods in Applied Genetic Epidemiology 2022” – a field that had witnessed considerable growth in recent years. Foley and Kuncheva, both seasoned industry experts, boast a wealth of accomplishments… Continue reading bioXcelerate AI Senior Team Recognized as Editors for Special Issue in Frontiers on Advances in Genetic Epidemiology
Category: News and insights
Tracing Genetic Mechanisms Underlying Human Disease
In collaboration with one of the world’s leading Translational Biology teams, based at Biogen US, Optima’s Chief Data Scientist Dr Chris Foley’s research into the heritability of human disease now features in Nature, the world’s leading multidisciplinary science journal. Along with lead authors Dr Benjamin Sun and Dr Heiko Runz, Dr Foley is contributing to an international… Continue reading Tracing Genetic Mechanisms Underlying Human Disease
How Data Science is Impacting Drug Development: Q and A with Dr Chris Foley
Q: What role does data science have in drug development today?Data is driving change in the drug development space. Drug development is complex, resource-heavy, and very costly. Collaborating across diverse specialisms – clinicians, chemists, geneticists, epidemiologists – scientists contribute their expertise. Notably, data scientists play a critical role in research, utilizing state-of-the-art data science and… Continue reading How Data Science is Impacting Drug Development: Q and A with Dr Chris Foley